At a glance
- Originator Academy of Sciences of the Czech Republic; Rega Institute for Medical Research
- Class Antivirals; Nucleosides
- Mechanism of Action DNA inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Viral infections
Most Recent Events
- 21 May 2001 No-Development-Reported for Viral infections in European Union (Unknown route)
- 21 May 1993 Preclinical development for Viral infections in European Union (Unknown route)